{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:47:27Z","timestamp":1790725647796,"version":"4.1.0"},"reference-count":221,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This review provides a summary of the currently available clinical data on drug\u2013drug interactions (DDIs) involving over-the-counter (OTC) medicines. It aims to educate and increase awareness among health care providers and to support decisions in daily practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>An extensive literature search was performed using bibliographic databases available through PubMed.gov. An initial structured search was performed using the keywords \u201cdrug-drug-interaction AND (over-the-counter OR OTC),\u201d without further restrictions except for the language. The initial results were screened for all described DDIs involving OTC drugs, and further information was gathered specifically on these drugs using dedicated database searches and references found in the bibliography from the initial hits.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From more than 1200 initial hits (1972\u2013June 2021), 408 relevant publications were screened for DDIs involving OTC drugs, leading to 2 major findings: first, certain types of drug regimens are more prone to DDIs or have more serious DDI-related consequences, such as antiretroviral, anti-infective, and oral anticancer therapies. Second, although most DDIs involve OTC drugs as the perpetrators, some prescription drugs (statins or phosphodiesterase-5 inhibitors) that currently have OTC status can be identified as the victims in DDIs. The following groups were identified to be frequently involved in DDIs: nonsteroidal anti-inflammatory drugs, food supplements, antacids, proton-pump inhibitors, H2 antihistamines, laxatives, antidiarrheal drugs, and herbal drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The most significant finding was the lack of high-quality evidence for commonly acknowledged interactions. High-quality interaction studies involving different phenotypes in drug metabolism (cytochrome P450) and distribution (transporters) are urgently needed. This should include modern and critical drugs, such as oral anticancer medications and direct oral anticoagulants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000924","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:17:40Z","timestamp":1630531060000},"page":"253-274","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Drug\u2013Drug Interactions With Over-The-Counter Medicines: Mind the Unprescribed"],"prefix":"10.1097","volume":"44","author":[{"given":"Oliver","family":"Scherf-Clavel","sequence":"first","affiliation":[{"name":"Institute for Pharmacy and Food Chemistry, University of W\u00fcrzburg, W\u00fcrzburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 11","key":"R1-20250603","first-page":"S69","article-title":"Over-the-counter medication: the drug interactions we overlook","volume":"30","author":"Lamy","year":"1982","journal-title":"J Am Geriatr Soc."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1345\/aph.1K207","article-title":"Survey of drug-related problems identified by community pharmacies","volume":"41","author":"H\u00e4mmerlein","year":"2007","journal-title":"Ann Pharmacother."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pds.2241","article-title":"Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany","volume":"21","author":"Eickhoff","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40264-014-0141-3","article-title":"Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study","volume":"37","author":"Schmiedl","year":"2014","journal-title":"Drug Saf."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11096-010-9409-6","article-title":"Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany","volume":"32","author":"Fiss","year":"2010","journal-title":"Pharm World Sci."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/ijpp.18.01.0011","article-title":"Appropriate use of non-prescription ibuprofen: a survey of patients' perceptions and understanding","volume":"18","author":"Ngo","year":"2010","journal-title":"Int J Pharm Pract."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11096-012-9718-z","article-title":"Characteristics of elderly patients who consider over-the-counter medications as safe","volume":"35","author":"Wawruch","year":"2013","journal-title":"Int J Clin Pharm."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1331\/JAPhA.2013.12038","article-title":"Assessing patients' information needs regarding drug-drug interactions","volume":"53","author":"Mutebi","year":"2013","journal-title":"J Am Pharm Assoc (2003)"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"531038","DOI":"10.3389\/fpubh.2020.531038","article-title":"Risk factors associated with medication errors among patients suffering from chronic disorders","volume":"8","author":"Rasool","year":"2020","journal-title":"Front Public Health"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s002280000145","article-title":"Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population","volume":"56","author":"Sihvo","year":"2000","journal-title":"Eur J Clin Pharmacol."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/geront\/gnu034","article-title":"Promoting safe and effective use of OTC medications: CHPA-GSA National Summit","volume":"54","author":"Albert","year":"2014","journal-title":"Gerontologist"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/fampra\/cml067","article-title":"Prevalence and predictors of polypharmacy among older primary care patients in Germany","volume":"24","author":"Junius-Walker","year":"2007","journal-title":"Fam Pract."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12877-018-0989-7","article-title":"Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA","volume":"18","author":"Sheikh-Taha","year":"2018","journal-title":"BMC Geriatr."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2147\/PPA.S173873","article-title":"Use patterns of over-the-counter (OTC) medications and perspectives on OTC medications among Korean adult patients with chronic diseases: gender and age differences","volume":"12","author":"Kim","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pds.3362","article-title":"Absence of 'over-the-counter' medicinal products in on-line prescription records: a risk factor of overlooking interactions in the elderly","volume":"22","author":"Olesen","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"e26410","DOI":"10.1002\/pbc.26410","article-title":"Drug-drug interactions in pediatric oncology patients","volume":"64","author":"Balk","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.gerinurse.2006.02.014","article-title":"Herbal, prescribed, and over-the-counter drug use in older women: prevalence of drug interactions","volume":"27","author":"Yoon","year":"2006","journal-title":"Geriatr Nurs."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/bmc.209","article-title":"Interaction of carbamazepine and promethazine in rabbits","volume":"17","author":"Rukhadze","year":"2003","journal-title":"Biomed Chromatogr."},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/taap.1996.0325","article-title":"Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice","volume":"141","author":"Bookstaff","year":"1996","journal-title":"Toxicol Appl Pharmacol."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1067\/mcp.2000.106464","article-title":"Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity","volume":"67","author":"Hamelin","year":"2000","journal-title":"Clin Pharmacol Ther."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004714-200104000-00009","article-title":"Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans","volume":"21","author":"Lessard","year":"2001","journal-title":"J Clin Psychopharmacol."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/jpet.104.081109","article-title":"Modulation of metoprolol pharmacokinetics and hemodynamics by diphenhydramine coadministration during exercise testing in healthy premenopausal women","volume":"313","author":"Sharma","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/17425255.2018.1496236","article-title":"Interaction between CYP2D6 inhibitor antidepressants and codeine: is this relevant?","volume":"14","author":"Cazet","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2217\/pgs-2018-0205","article-title":"Drug-gene and drug-drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial","volume":"20","author":"Fulton","year":"2019","journal-title":"Pharmacogenomics"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.2013.254","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update","volume":"95","author":"Crews","year":"2014","journal-title":"Clin Pharmacol Ther."},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bcp.13887","article-title":"Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon","volume":"85","author":"Lokhorst","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/00912700122010302","article-title":"Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr","volume":"41","author":"Hendershot","year":"2001","journal-title":"J Clin Pharmacol."},{"key":"R28-20250603","first-page":"497","article-title":"Self-medication for cough and the common cold: information needs of consumers","volume":"44","author":"Kloosterboer","year":"2015","journal-title":"Aust Fam Physician"},{"key":"R29-20250603","first-page":"201","article-title":"The effects of pseudoephedrine on blood pressure in patients with controlled, uncomplicated hypertension: a randomized, double-blind, placebo-controlled trial","volume":"4","author":"Bradley","year":"1991","journal-title":"J Am Board Fam Pract."},{"key":"R30-20250603","first-page":"22","article-title":"Does pseudoephedrine increase blood pressure in patients with controlled hypertension?","volume":"40","author":"Coates","year":"1995","journal-title":"J Fam Pract."},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002280050624","article-title":"No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with beta-blockers","volume":"55","author":"Mores","year":"1999","journal-title":"Eur J Clin Pharmacol."},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2125.1989.tb05441.x","article-title":"A controlled clinical trial on the cardiovascular effects of single doses of pseudoephedrine in hypertensive patients","volume":"28","author":"Chua","year":"1989","journal-title":"Br J Clin Pharmacol."},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archinte.1992.00400180098015","article-title":"Cardiovascular effects of pseudoephedrine in medically controlled hypertensive patients","volume":"152","author":"Beck","year":"1992","journal-title":"Arch Intern Med."},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00000441-198910000-00010","article-title":"Pseudoephedrine accumulation in renal failure","volume":"298","author":"Sica","year":"1989","journal-title":"Am J Med Sci."},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0000000000000031","article-title":"Ambroxol-induced focal epileptic seizure","volume":"37","author":"Lapenta","year":"2014","journal-title":"Clin Neuropharmacol."},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/17512433.2017.1246180","article-title":"Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products","volume":"10","author":"Brooks","year":"2017","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/jac\/dkw032","article-title":"Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications","volume":"71","author":"Marzolini","year":"2016","journal-title":"J Antimicrob Chemother."},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11845-019-02125-1","article-title":"Pharmacokinetic enhancers (cobicistat\/ritonavir) and the potential for drug-drug interactions","volume":"189","author":"Hollywood","year":"2020","journal-title":"Ir J Med Sci."},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/hiv.12039","article-title":"Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management","volume":"14","author":"Saberi","year":"2013","journal-title":"HIV Med."},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1128\/AAC.49.12.4903-4910.2005","article-title":"Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers","volume":"49","author":"Mukwaya","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"R41-20250603","first-page":"405","article-title":"Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement","volume":"70","author":"Tayrouz","year":"2001","journal-title":"Clin Pharmacol Ther."},{"key":"R42-20250603","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/oby.22240","article-title":"Loss of control of HIV viremia with OTC weight-loss drugs: a call for caution?","volume":"26","author":"Cattaneo","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"R43-20250603","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0190-9622(99)70055-1","article-title":"Drug interactions with itraconazole, fluconazole, and terbinafine and their management","volume":"41","author":"Gupta","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"R44-20250603","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2710.2010.01229.x","article-title":"Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model","volume":"36","author":"Miki","year":"2011","journal-title":"J Clin Pharm Ther."},{"key":"R45-20250603","first-page":"897190020977762","article-title":"When coadministration cannot be avoided: real world experience of direct acting antivirals for the treatment of hepatitis C virus infection in patients on first generation anticonvulsants","author":"Natali","year":"2020","journal-title":"J Pharm Pract."},{"key":"R46-20250603","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldp001","article-title":"Should sildenafil be available over the counter?","volume":"90","author":"Rubin","year":"2009","journal-title":"Br Med Bull."},{"key":"R47-20250603","doi-asserted-by":"crossref","first-page":"100368","DOI":"10.1016\/j.dmpk.2020.11.003","article-title":"The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects","volume":"36","author":"Lee","year":"2021","journal-title":"Drug Metab Pharmacokinet."},{"key":"R48-20250603","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003088-200847070-00003","article-title":"Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin","volume":"47","author":"Neuvonen","year":"2008","journal-title":"Clin Pharmacokinet."},{"key":"R49-20250603","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.amjcard.2004.08.007","article-title":"A consumer use study of over-the-counter lovastatin (CUSTOM)","volume":"94","author":"Melin","year":"2004","journal-title":"Am J Cardiol."},{"key":"R50-20250603","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00325481.1992.11701373","article-title":"Over-the-counter medications. Do you know what your patients are taking?","volume":"91","author":"Holden","year":"1992","journal-title":"Postgrad Med."},{"key":"R51-20250603","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2165\/11593990-000000000-00000","article-title":"Clinically significant drug interactions with antacids: an update","volume":"71","author":"Ogawa","year":"2011","journal-title":"Drugs"},{"key":"R52-20250603","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0773.1999.tb00883.x","article-title":"Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments","volume":"84","author":"Mersebach","year":"1999","journal-title":"Pharmacol Toxicol."},{"key":"R53-20250603","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1345\/aph.1A031","article-title":"Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders","volume":"35","author":"Csako","year":"2001","journal-title":"Ann Pharmacother."},{"key":"R54-20250603","first-page":"39","article-title":"Interaction between levothyroxine and calcium carbonate","volume":"54","author":"Mazokopakis","year":"2008","journal-title":"Can Fam Physician"},{"key":"R55-20250603","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/105072501753211046","article-title":"The acute effect of calcium carbonate on the intestinal absorption of levothyroxine","volume":"11","author":"Singh","year":"2001","journal-title":"Thyroid"},{"key":"R56-20250603","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00004045-200405000-00015","article-title":"Levothyroxine and calcium interaction: timing is everything","volume":"22","author":"Neafsey","year":"2004","journal-title":"Home Healthc Nurse"},{"key":"R57-20250603","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jac\/dkg089","article-title":"A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution","volume":"51","author":"Johnson","year":"2003","journal-title":"J Antimicrob Chemother."},{"key":"R58-20250603","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050438","article-title":"Effect of omeprazole on the pharmacokinetics of itraconazole","volume":"54","author":"Jaruratanasirikul","year":"1998","journal-title":"Eur J Clin Pharmacol."},{"key":"R59-20250603","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11096-015-0150-z","article-title":"The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors","volume":"37","author":"Boardman","year":"2015","journal-title":"Int J Clin Pharm."},{"key":"R60-20250603","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2146\/ajhp070226","article-title":"Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir","volume":"65","author":"Tappouni","year":"2008","journal-title":"Am J Health Syst Pharm."},{"key":"R61-20250603","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1592\/phco.28.1.42","article-title":"Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects","volume":"28","author":"Fang","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R62-20250603","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1592\/phco.26.3.341","article-title":"Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers","volume":"26","author":"Tomilo","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R63-20250603","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0091270007313392","article-title":"Effects of acid-reducing agents on the pharmacokinetics of lopinavir\/ritonavir and ritonavir-boosted atazanavir","volume":"48","author":"Klein","year":"2008","journal-title":"J Clin Pharmacol."},{"key":"R64-20250603","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.qai.0000192002.23400.6e","article-title":"Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?","volume":"41","author":"Furtek","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"R65-20250603","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1345\/aph.1H217","article-title":"Clinical outcomes associated with concomitant use of atazanavir and proton pump inhibitors","volume":"40","author":"Sahloff","year":"2006","journal-title":"Ann Pharmacother."},{"key":"R66-20250603","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1468-1293.2007.00456.x","article-title":"Concomitant use of gastric acid-reducing agents is frequent among HIV-1-infected patients receiving protease inhibitor-based highly active antiretroviral therapy","volume":"8","author":"van Lunzen","year":"2007","journal-title":"HIV Med."},{"key":"R67-20250603","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.healun.2009.03.006","article-title":"Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients","volume":"28","author":"Kofler","year":"2009","journal-title":"J Heart Lung Transpl."},{"key":"R68-20250603","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3350\/cmh.2020.0180","article-title":"Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis","volume":"27","author":"Hsu","year":"2021","journal-title":"Clin Mol Hepatol."},{"key":"R69-20250603","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.aids.0000233573.41597.8a","article-title":"Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers","volume":"20","author":"Winston","year":"2006","journal-title":"AIDS"},{"key":"R70-20250603","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1211\/0022357043914","article-title":"Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations","volume":"56","author":"Itagaki","year":"2004","journal-title":"J Pharm Pharmacol."},{"key":"R71-20250603","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fmed.2018.00320","article-title":"Pantoprazole does not affect serum trough levels of tacrolimus and everolimus in liver transplant recipients","volume":"5","author":"Bremer","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R72-20250603","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1124\/dmd.112.045575","article-title":"Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19","volume":"40","author":"Zvyaga","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"R73-20250603","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40264-014-0144-0","article-title":"Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update","volume":"37","author":"Wedemeyer","year":"2014","journal-title":"Drug Saf."},{"issue":"suppl 1","key":"R74-20250603","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.5152\/tjg.2017.17","article-title":"When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?","volume":"28","author":"Celebi","year":"2017","journal-title":"Turk J Gastroenterol."},{"key":"R75-20250603","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/AAC.35.9.1765","article-title":"Effects of ranitidine and sucralfate on ketoconazole bioavailability","volume":"35","author":"Piscitelli","year":"1991","journal-title":"Antimicrob Agents Chemother."},{"key":"R76-20250603","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2036.1993.tb00103.x","article-title":"Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity","volume":"7","author":"Lim","year":"1993","journal-title":"Aliment Pharmacol Ther."},{"key":"R77-20250603","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1018918316253","article-title":"pH-related changes in the absorption of dipyridamole in the elderly","volume":"11","author":"Russell","year":"1994","journal-title":"Pharm Res."},{"key":"R78-20250603","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12032-019-1267-z","article-title":"Interaction between phytotherapy and oral anticancer agents: prospective study and literature review","volume":"36","author":"Boiteux-Jurain","year":"2019","journal-title":"Med Oncol."},{"key":"R79-20250603","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CAD.0000000000000212","article-title":"Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine","volume":"26","author":"Kletzl","year":"2015","journal-title":"Anticancer Drugs"},{"key":"R80-20250603","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cllc.2014.07.005","article-title":"Gastric Acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer","volume":"16","author":"Chu","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"R81-20250603","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.clgc.2017.05.019","article-title":"Proton pump inhibitors and survival outcomes in patients with metastatic renal cell carcinoma","volume":"15","author":"Lalani","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"R82-20250603","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bcp.12895","article-title":"Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia","volume":"81","author":"Pape","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"R83-20250603","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(14)70458-9","article-title":"Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye","volume":"15","author":"Yu","year":"2014","journal-title":"Lancet Oncol."},{"key":"R84-20250603","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/clpt.2012.73","article-title":"Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?","volume":"92","author":"Budha","year":"2012","journal-title":"Clin Pharmacol Ther."},{"key":"R85-20250603","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cpdd.356","article-title":"Impact of acid-reducing agents on the pharmacokinetics of palbociclib, a weak base with ph-dependent solubility, with different food intake conditions","volume":"6","author":"Sun","year":"2017","journal-title":"Clin Pharmacol Drug Dev."},{"key":"R86-20250603","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/0091270009333854","article-title":"Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects","volume":"49","author":"Eley","year":"2009","journal-title":"J Clin Pharmacol."},{"key":"R87-20250603","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/jphp.12983","article-title":"Effects of medicines used to treat gastrointestinal diseases on the pharmacokinetics of coadministered drugs: a PEARRL Review","volume":"71","author":"Litou","year":"2019","journal-title":"J Pharm Pharmacol."},{"key":"R88-20250603","first-page":"1273","article-title":"Effect of laxatives and metoclopramide on plasma quinidine concentration during prolonged administration in patients with heart rhythm disorders [in German]","volume":"27","author":"Guckenbiehl","year":"1976","journal-title":"Med Welt"},{"key":"R89-20250603","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.1999.00025.x","article-title":"Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers","volume":"48","author":"Ragueneau","year":"1999","journal-title":"Br J Clin Pharmacol."},{"key":"R90-20250603","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jamda.2016.06.024","article-title":"PEG and thickeners: a critical interaction between polyethylene glycol laxative and starch-based thickeners","volume":"17","author":"Carlisle","year":"2016","journal-title":"J Am Med Dir Assoc."},{"key":"R91-20250603","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002280050633","article-title":"Changes in gastrointestinal motility influence the absorption of desmopressin","volume":"55","author":"Callr\u00e9us","year":"1999","journal-title":"Eur J Clin Pharmacol."},{"key":"R92-20250603","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2165\/00003088-200443140-00004","article-title":"Reduction of saquinavir exposure by coadministration of loperamide: a two-way pharmacokinetic interaction","volume":"43","author":"Mikus","year":"2004","journal-title":"Clin Pharmacokinet."},{"key":"R93-20250603","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0167-5273(94)02212-2","article-title":"Activated charcoal increases digoxin elimination in patients","volume":"48","author":"Iba\u00f1ez","year":"1995","journal-title":"Int J Cardiol."},{"key":"R94-20250603","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humrep\/16.1.76","article-title":"Charcoal treatment and risk of escape ovulation in oral contraceptive users","volume":"16","author":"Elomaa","year":"2001","journal-title":"Hum Reprod."},{"key":"R95-20250603","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-4732-2-2","article-title":"OTC analgesics and drug interactions: clinical implications","volume":"2","author":"Fendrick","year":"2008","journal-title":"Osteopath Med Prim Care"},{"key":"R96-20250603","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s11096-020-00984-8","article-title":"Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications","volume":"42","author":"Yla-Rautio","year":"2020","journal-title":"Int J Clin Pharm-Net."},{"key":"R97-20250603","first-page":"2218","article-title":"Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs","volume":"32","author":"Wilcox","year":"2005","journal-title":"J Rheumatol."},{"key":"R98-20250603","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/jep.12193","article-title":"A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned","volume":"20","author":"Miller","year":"2014","journal-title":"J Eval Clin Pract."},{"key":"R99-20250603","first-page":"1061","article-title":"Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs","volume":"11","author":"Moore","year":"2015","journal-title":"Ther Clin Risk Manag."},{"key":"R100-20250603","first-page":"137","article-title":"Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding","volume":"5","author":"Blot","year":"2000","journal-title":"J Epidemiol Biostat."},{"key":"R101-20250603","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2005.08.051","article-title":"Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs","volume":"129","author":"Lewis","year":"2005","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"R102-20250603","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.clinthera.2007.12.003","article-title":"Adverse drug interactions involving common prescription and over-the-counter analgesic agents","volume":"29","author":"Hersh","year":"2007","journal-title":"Clin Ther."},{"key":"R103-20250603","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clinthera.2005.01.011","article-title":"Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers","volume":"27","author":"Cryer","year":"2005","journal-title":"Clin Ther."},{"key":"R104-20250603","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1185\/03007995.2010.481249","article-title":"Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2","volume":"26","author":"Oldenhof","year":"2010","journal-title":"Curr Med Res Opin."},{"key":"R105-20250603","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/a-1157-9433","article-title":"Drug-drug interactions between lithium and cardiovascular as well as anti-inflammatory drugs","volume":"53","author":"Scherf-Clavel","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"R106-20250603","doi-asserted-by":"crossref","first-page":"m315","DOI":"10.1136\/bmj.m315","article-title":"Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials","volume":"368","author":"Huang","year":"2020","journal-title":"BMJ"},{"key":"R107-20250603","first-page":"857","article-title":"Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients","volume":"81","author":"Liel","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"R108-20250603","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/thy.2007.0222","article-title":"Altered intestinal absorption of L-thyroxine caused by coffee","volume":"18","author":"Benvenga","year":"2008","journal-title":"Thyroid"},{"key":"R109-20250603","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0140-6736(90)90256-5","article-title":"Interaction between lithium salts and ispaghula husk","volume":"335","author":"Perlman","year":"1990","journal-title":"Lancet"},{"key":"R110-20250603","first-page":"67","article-title":"Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients","volume":"5","author":"Nordstr\u00f6m","year":"1987","journal-title":"Drug Nutr Interact"},{"key":"R111-20250603","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF01733197","article-title":"The effect of wheat bran on the pharmacokinetics of phenprocoumon in normal volunteers","volume":"63","author":"Kitteringham","year":"1985","journal-title":"Klin Wochenschr"},{"key":"R112-20250603","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2165\/00003495-200262100-00005","article-title":"Food-drug interactions","volume":"62","author":"Schmidt","year":"2002","journal-title":"Drugs"},{"key":"R113-20250603","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00498250110060950","article-title":"Assessment of drug-drug interactions: concepts and approaches","volume":"31","author":"Weaver","year":"2001","journal-title":"Xenobiotica"},{"key":"R114-20250603","doi-asserted-by":"crossref","first-page":"76S","DOI":"10.1016\/0002-9343(89)90028-4","article-title":"Drug-drug interactions with ciprofloxacin and other fluoroquinolones","volume":"87","author":"Polk","year":"1989","journal-title":"Am J Med."},{"key":"R115-20250603","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jcph.439","article-title":"Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects","volume":"55","author":"Song","year":"2015","journal-title":"J Clin Pharmacol."},{"key":"R116-20250603","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40121-020-00307-4","article-title":"HIV-1 virologic rebound due to coadministration of divalent cations and bictegravir","volume":"9","author":"Rock","year":"2020","journal-title":"Infect Dis Ther."},{"key":"R117-20250603","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1200\/JCO.2007.15.9426","article-title":"Severe sequence-specific toxicity when capecitabine is given after fluorouracil and leucovorin","volume":"26","author":"Hennig","year":"2008","journal-title":"J Clin Oncol."},{"key":"R118-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425255.2021.1867105","article-title":"Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy","volume":"17","author":"Bechtold","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R119-20250603","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s12906-017-2052-1","article-title":"Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey","volume":"17","author":"McLay","year":"2017","journal-title":"BMC Complement Altern Med."},{"key":"R120-20250603","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11239-019-01945-3","article-title":"Interactions between clopidogrel and traditional Chinese medicine","volume":"48","author":"Hu","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"R121-20250603","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biopha.2016.06.012","article-title":"Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy","volume":"83","author":"Leite","year":"2016","journal-title":"Biomed Pharmacother."},{"key":"R122-20250603","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3389\/fonc.2019.01356","article-title":"Herbal interaction with chemotherapeutic drugs-a focus on clinically significant findings","volume":"9","author":"Fasinu","year":"2019","journal-title":"Front Oncol."},{"key":"R123-20250603","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00228-019-02700-6","article-title":"Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment","volume":"75","author":"Ziemann","year":"2019","journal-title":"Eur J Clin Pharmacol."},{"key":"R124-20250603","article-title":"Use of complementary or alternative medicine and potential interactions with chronic medications among Chinese survivors of childhood cancer","author":"Lam","year":"2021","journal-title":"J Cancer Surviv"},{"key":"R125-20250603","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1200\/JOP.2017.020859","article-title":"Potential drug-drug and herb-drug interactions in patients with cancer: a prospective study of medication surveillance","volume":"13","author":"Ramos-Esquivel","year":"2017","journal-title":"J Oncol Pract."},{"key":"R126-20250603","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00002512-200522060-00006","article-title":"Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba","volume":"22","author":"Gurley","year":"2005","journal-title":"Drugs Aging"},{"key":"R127-20250603","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2165\/00003495-200565090-00005","article-title":"Herb-drug interactions: a literature review","volume":"65","author":"Hu","year":"2005","journal-title":"Drugs"},{"key":"R128-20250603","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(99)06457-0","article-title":"Herb-drug interactions","volume":"355","author":"Fugh-Berman","year":"2000","journal-title":"Lancet"},{"key":"R129-20250603","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2174\/0929867043365198","article-title":"Herb-drug interactions: an evidence based approach","volume":"11","author":"Coxeter","year":"2004","journal-title":"Curr Med Chem."},{"key":"R130-20250603","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1534735409340900","article-title":"Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals","volume":"8","author":"Shord","year":"2009","journal-title":"Integr Cancer Ther."},{"key":"R131-20250603","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2174\/138920008786927785","article-title":"Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration","volume":"9","author":"Ulbricht","year":"2008","journal-title":"Curr Drug Metab."},{"key":"R132-20250603","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00002018-200427110-00003","article-title":"Drug interactions with St John's wort: mechanisms and clinical implications","volume":"27","author":"Mannel","year":"2004","journal-title":"Drug Saf."},{"key":"R133-20250603","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","volume":"97","author":"Moore","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"R134-20250603","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/17425255.2017.1378342","article-title":"Clinical risks of St John's wort (Hypericum perforatum) co-administration","volume":"13","author":"Soleymani","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R135-20250603","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jphp.12858","article-title":"Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content","volume":"71","author":"Chrubasik-Hausmann","year":"2019","journal-title":"J Pharm Pharmacol."},{"key":"R136-20250603","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2020.12.002","article-title":"Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system","volume":"103","author":"Sunaga","year":"2020","journal-title":"Contraception"},{"key":"R137-20250603","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.contraception.2016.07.010","article-title":"Co-administration of St. John's wort and hormonal contraceptives: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"R138-20250603","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1111\/bcp.13757","article-title":"Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided","volume":"84","author":"Huppertz","year":"2018","journal-title":"Br J Clin Pharmacol."},{"key":"R139-20250603","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/bcp.14553","article-title":"Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans","volume":"87","author":"Scholz","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"R140-20250603","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jgs.16193","article-title":"Prevalence and knowledge of potential interactions between over-the-counter products and apixaban","volume":"68","author":"Tarn","year":"2020","journal-title":"J Am Geriatr Soc."},{"key":"R141-20250603","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1128\/AAC.00672-12","article-title":"Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers","volume":"56","author":"Blonk","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"R142-20250603","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/00498254.2013.773385","article-title":"Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and Ginkgo biloba extracts in healthy subjects","volume":"43","author":"Dai","year":"2013","journal-title":"Xenobiotica"},{"key":"R143-20250603","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3109\/00498254.2012.661100","article-title":"Effects of Ginkgo biloba extracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices","volume":"42","author":"Guo","year":"2012","journal-title":"Xenobiotica"},{"key":"R144-20250603","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/03602532.2013.815200","article-title":"Pharmacokinetic drug interactions involving Ginkgo biloba","volume":"45","author":"Unger","year":"2013","journal-title":"Drug Metab Rev."},{"key":"R145-20250603","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.phrs.2019.01.028","article-title":"Interaction of herbal products with prescribed medications: a systematic review and meta-analysis","volume":"141","author":"Awortwe","year":"2019","journal-title":"Pharmacol Res."},{"key":"R146-20250603","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-011-1174-5","article-title":"Effect of Ginkgo biloba special extract EGb 761(R) on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers","volume":"68","author":"Zadoyan","year":"2012","journal-title":"Eur J Clin Pharmacol."},{"key":"R147-20250603","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jat\/29.7.755","article-title":"Fatal seizures due to potential herb-drug interactions with Ginkgo biloba","volume":"29","author":"Kupiec","year":"2005","journal-title":"J Anal Toxicol."},{"key":"R148-20250603","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(87)90066-3","article-title":"Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man","volume":"1","author":"Chung","year":"1987","journal-title":"Lancet"},{"key":"R149-20250603","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2125.2006.02759.x","article-title":"Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects","volume":"63","author":"Aruna","year":"2007","journal-title":"Br J Clin Pharmacol."},{"key":"R150-20250603","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.clinthera.2010.01.027","article-title":"Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: an open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers","volume":"32","author":"Kim","year":"2010","journal-title":"Clin Ther."},{"key":"R151-20250603","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.yrtph.2015.10.009","article-title":"Adverse food-drug interactions","volume":"73","author":"de Boer","year":"2015","journal-title":"Regul Toxicol Pharmacol."},{"key":"R152-20250603","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0021-9150(03)00015-7","article-title":"Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen","volume":"167","author":"Meisel","year":"2003","journal-title":"Atherosclerosis"},{"key":"R153-20250603","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/01197065-200502030-00007","article-title":"Effects of Ginkgo biloba on blood coagulation parameters","volume":"2","author":"Savovi\u0107","year":"2005","journal-title":"Evidence-Based Integr Med."},{"key":"R154-20250603","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s12272-019-01184-3","article-title":"Interactions of ginseng with therapeutic drugs","volume":"42","author":"Choi","year":"2019","journal-title":"Arch Pharm Res."},{"key":"R155-20250603","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1067\/mcp.2002.126913","article-title":"Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans","volume":"72","author":"Gurley","year":"2002","journal-title":"Clin Pharmacol Ther."},{"key":"R156-20250603","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0043-100934","article-title":"An appraisal of drug-drug interactions with green tea (Camellia sinensis)","volume":"83","author":"Albassam","year":"2017","journal-title":"Planta Med."},{"key":"R157-20250603","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pharmthera.2012.08.001","article-title":"Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport","volume":"136","author":"Won","year":"2012","journal-title":"Pharmacol Ther."},{"key":"R158-20250603","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.phrs.2016.09.038","article-title":"Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John's Wort?","volume":"118","author":"Mouly","year":"2017","journal-title":"Pharmacol Res."},{"issue":"suppl 1","key":"R159-20250603","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000115345","article-title":"Food and drug interaction: consequences for the nutrition\/health status","volume":"52","author":"Genser","year":"2008","journal-title":"Ann Nutr Metab."},{"key":"R160-20250603","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4065\/75.9.933","article-title":"Drug-grapefruit juice interactions","volume":"75","author":"Kane","year":"2000","journal-title":"Mayo Clin Proc."},{"key":"R161-20250603","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.dmpk.2015.06.005","article-title":"The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion","volume":"30","author":"Akamine","year":"2015","journal-title":"Drug Metab Pharmacokinet."},{"key":"R162-20250603","first-page":"389","article-title":"Over-the-counter drugs to avoid in older adults with kidney impairment","volume":"43","author":"Hess","year":"2016","journal-title":"Nephrol Nurs J."},{"key":"R163-20250603","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2006.11.023","article-title":"Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency","volume":"49","author":"Lalibert\u00e9","year":"2007","journal-title":"Am J Kidney Dis."},{"key":"R164-20250603","first-page":"e13396","article-title":"Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: a descriptive cross-sectional study","volume":"30","author":"Lachuer","year":"2020","journal-title":"Eur J Cancer Care (Engl)."},{"key":"R165-20250603","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-014-1786-7","article-title":"Drug-drug interaction software in clinical practice: a systematic review","volume":"71","author":"Roblek","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"R166-20250603","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.sapharm.2019.11.013","article-title":"A pilot study of decision factors influencing over-the-counter medication selection and use by older adults","volume":"16","author":"Stone","year":"2020","journal-title":"Res Soc Adm Pharm."},{"key":"R167-20250603","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40256-016-0172-5","article-title":"Drug interaction between clopidogrel and ranitidine or omeprazole in stable coronary artery disease: a double-blind, double dummy, randomized study","volume":"16","author":"Furtado","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"R168-20250603","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2011.12.024","article-title":"A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers","volume":"59","author":"Frelinger","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"R169-20250603","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2003-39980","article-title":"Omeprazole reduces clozapine plasma concentrations. A case report","volume":"36","author":"Frick","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"R170-20250603","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1001\/jama.283.21.2822","article-title":"Effect of calcium carbonate on the absorption of levothyroxine","volume":"283","author":"Singh","year":"2000","journal-title":"JAMA"},{"key":"R171-20250603","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2143\/ACB.3347","article-title":"Drug-related admissions due to interaction with an old drug, lithium","volume":"68","author":"De Winter","year":"2013","journal-title":"Acta Clin Belg."},{"key":"R172-20250603","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0895-7061(02)03203-X","article-title":"Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors","volume":"16","author":"Palmer","year":"2003","journal-title":"Am J Hypertens."},{"key":"R173-20250603","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(99)00075-8","article-title":"Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs","volume":"12","author":"Thakur","year":"1999","journal-title":"Am J Hypertens."},{"key":"R174-20250603","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1742-1241.2010.02346.x","article-title":"The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents","volume":"64","author":"MacDonald","year":"2010","journal-title":"Int J Clin Pract."},{"key":"R175-20250603","doi-asserted-by":"crossref","first-page":"M74","DOI":"10.1093\/gerona\/51A.2.M74","article-title":"The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons","volume":"51","author":"Gurwitz","year":"1996","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"R176-20250603","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/J354v20n03_03","article-title":"Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs","volume":"20","author":"Biskupiak","year":"2006","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"R177-20250603","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/DMDI.1998.14.3.193","article-title":"Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers","volume":"14","author":"van Hecken","year":"1998","journal-title":"Drug Metabol Drug Interact"},{"key":"R178-20250603","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archinte.1995.00430100075009","article-title":"The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil","volume":"155","author":"Houston","year":"1995","journal-title":"Arch Intern Med."},{"key":"R179-20250603","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2261-12-93","article-title":"Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension","volume":"12","author":"Aljadhey","year":"2012","journal-title":"BMC Cardiovasc Disord."},{"key":"R180-20250603","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00045391-200307000-00003","article-title":"Impact of ginkgo biloba on the pharmacokinetics of digoxin","volume":"10","author":"Mauro","year":"2003","journal-title":"Am J Ther."},{"key":"R181-20250603","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1185\/030079908X260871","article-title":"Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects","volume":"24","author":"Robertson","year":"2008","journal-title":"Curr Med Res Opin."},{"key":"R182-20250603","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1177\/0091270006292628","article-title":"Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers","volume":"46","author":"Uchida","year":"2006","journal-title":"J Clin Pharmacol."},{"key":"R183-20250603","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1345\/aph.1L656","article-title":"Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers","volume":"43","author":"Fan","year":"2009","journal-title":"Ann Pharmacother."},{"key":"R184-20250603","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002280050183","article-title":"Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers","volume":"51","author":"Josefsson","year":"1996","journal-title":"Eur J Clin Pharmacol."},{"key":"R185-20250603","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0009-9236(98)90056-X","article-title":"Grapefruit juice substantially increases plasma concentrations of buspirone","volume":"64","author":"Lilja","year":"1998","journal-title":"Clin Pharmacol Ther."},{"key":"R186-20250603","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0009-9236(98)90177-1","article-title":"Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy","volume":"64","author":"Garg","year":"1998","journal-title":"Clin Pharmacol Ther."},{"key":"R187-20250603","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(95)90700-9","article-title":"Effect of grapefruit juice on blood cyclosporin concentration","volume":"345","author":"Yee","year":"1995","journal-title":"Lancet"},{"key":"R188-20250603","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2125.1995.tb04459.x","article-title":"Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function","volume":"39","author":"Proppe","year":"1995","journal-title":"Br J Clin Pharmacol."},{"key":"R189-20250603","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00266354","article-title":"Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine\u2013and its potential clinical relevance","volume":"42","author":"Edgar","year":"1992","journal-title":"Eur J Clin Pharmacol."},{"key":"R190-20250603","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00192360","article-title":"Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects","volume":"49","author":"Lundahl","year":"1995","journal-title":"Eur J Clin Pharmacol."},{"key":"R191-20250603","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002280050263","article-title":"Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men","volume":"52","author":"Lundahl","year":"1997","journal-title":"Eur J Clin Pharmacol."},{"key":"R192-20250603","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2125.2004.02095.x","article-title":"Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin","volume":"58","author":"Lilja","year":"2004","journal-title":"Br J Clin Pharmacol."},{"key":"R193-20250603","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0009-9236(98)90130-8","article-title":"Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors","volume":"64","author":"Lilja","year":"1998","journal-title":"Clin Pharmacol Ther."},{"key":"R194-20250603","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2133\/dmpk.21.122","article-title":"Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient","volume":"21","author":"Fukatsu","year":"2006","journal-title":"Drug Metab Pharmacokinet."},{"key":"R195-20250603","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00228-009-0702-z","article-title":"Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study","volume":"65","author":"Liu","year":"2009","journal-title":"Eur J Clin Pharmacol."},{"key":"R196-20250603","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0009-9236(96)90105-8","article-title":"Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram","volume":"59","author":"Benton","year":"1996","journal-title":"Clin Pharmacol Ther."},{"key":"R197-20250603","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1742-7843.2010.00582.x","article-title":"Grapefruit juice enhances the exposure to oral oxycodone","volume":"107","author":"Nieminen","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"R198-20250603","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FJC.0b013e3181ffe8d0","article-title":"The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity","volume":"57","author":"Lau","year":"2011","journal-title":"J Cardiovasc Pharmacol."},{"key":"R199-20250603","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.2003.01759.x","article-title":"Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients","volume":"55","author":"Bauer","year":"2003","journal-title":"Br J Clin Pharmacol."},{"key":"R200-20250603","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1067\/mcp.2002.124080","article-title":"Effect of St John's wort on the pharmacokinetics of fexofenadine","volume":"71","author":"Wang","year":"2002","journal-title":"Clin Pharmacol Ther."},{"key":"R201-20250603","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(99)05712-8","article-title":"Indinavir concentrations and St John's wort","volume":"355","author":"Piscitelli","year":"2000","journal-title":"Lancet"},{"key":"R202-20250603","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/94.16.1247","article-title":"Effects of St. John's wort on irinotecan metabolism","volume":"94","author":"Mathijssen","year":"2002","journal-title":"J Natl Cancer Inst."},{"key":"R203-20250603","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(91)90872-M","article-title":"Interaction of citrus juices with felodipine and nifedipine","volume":"337","author":"Bailey","year":"1991","journal-title":"Lancet"},{"key":"R204-20250603","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ndt\/gfg002","article-title":"Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients","volume":"18","author":"Mai","year":"2003","journal-title":"Nephrol Dial Transpl."},{"key":"R205-20250603","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00007890-200203270-00035","article-title":"Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort","volume":"73","author":"Bolley","year":"2002","journal-title":"Transplantation"},{"key":"R206-20250603","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejpain.2009.12.007","article-title":"St John's wort greatly reduces the concentrations of oral oxycodone","volume":"14","author":"Nieminen","year":"2010","journal-title":"Eur J Pain"},{"key":"R207-20250603","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2125.2003.02051.x","article-title":"Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects","volume":"57","author":"Jiang","year":"2004","journal-title":"Br J Clin Pharmacol."},{"key":"R208-20250603","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1592\/phco.30.1.110","article-title":"Probable warfarin interaction with menthol cough drops","volume":"30","author":"Coderre","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R209-20250603","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7196\/SAMJ.3848","article-title":"Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide","volume":"100","author":"Gray","year":"2010","journal-title":"S Afr Med J."},{"key":"R210-20250603","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1345\/aph.1K075","article-title":"Exogenous Cushing syndrome with inhaled fluticasone in a child receiving lopinavir\/ritonavir","volume":"41","author":"Bhumbra","year":"2007","journal-title":"Ann Pharmacother."},{"key":"R211-20250603","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-199909100-00038","article-title":"Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone","volume":"13","author":"Hillebrand-Haverkort","year":"1999","journal-title":"AIDS"},{"key":"R212-20250603","first-page":"274","article-title":"Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone","volume":"75","author":"Chen","year":"1999","journal-title":"Sex Transm Infect."},{"key":"R213-20250603","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4158\/EP09288.CR","article-title":"Iatrogenic osteoporosis, bilateral HIP osteonecrosis, and secondary adrenal suppression in an HIV-infected man receiving inhaled corticosteroids and ritonavir-boosted highly active antiretroviral therapy","volume":"17","author":"Kaviani","year":"2011","journal-title":"Endocr Pract."},{"key":"R214-20250603","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.amjcard.2004.07.080","article-title":"Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors","volume":"94","author":"Jacobson","year":"2004","journal-title":"Am J Cardiol."},{"key":"R216-20250603","first-page":"801","article-title":"Assessment of potential interaction between simvastatin and clarithromycin in healthy adult male subjects","volume":"31","author":"Kaleem","year":"2018","journal-title":"Pak J Pharm Sci."},{"key":"R217-20250603","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1345\/aph.1G195","article-title":"Simvastatin interaction with clarithromycin and amiodarone causing myositis","volume":"39","author":"Chouhan","year":"2005","journal-title":"Ann Pharmacother."},{"key":"R218-20250603","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1345\/aph.10177","article-title":"Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin","volume":"35","author":"Lee","year":"2001","journal-title":"Ann Pharmacother."},{"key":"R219-20250603","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/imj.12464","article-title":"Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin","volume":"44","author":"Page","year":"2014","journal-title":"Intern Med J."},{"key":"R220-20250603","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/bdd.488","article-title":"The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers","volume":"27","author":"Hedaya","year":"2006","journal-title":"Biopharm Drug Dispos."},{"issue":"suppl 1","key":"R221-20250603","first-page":"37S","article-title":"The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers","volume":"53","author":"Muirhead","year":"2002","journal-title":"Br J Clin Pharmacol."},{"key":"R222-20250603","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2125.2000.00245.x","article-title":"Pharmacokinetic interactions between sildenafil and saquinavir\/ritonavir","volume":"50","author":"Muirhead","year":"2000","journal-title":"Br J Clin Pharmacol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:20:49Z","timestamp":1748971249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":221,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000924","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2021-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}